Immuneering Ownership | Who Owns Immuneering?
Immuneering Ownership Summary
Immuneering is owned by 10.78% institutional investors, 24.12% insiders, and 65.10% retail investors. Citadel advisors is the largest institutional shareholder, holding 6.41% of IMRX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.97% of its assets in Immuneering shares.
IMRX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Immuneering | 10.78% | 24.12% | 65.10% |
| Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
| Industry | Biotech Stocks | 306.59% | 11.10% | -217.69% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Citadel advisors | 1.88M | 6.41% | $2.41M |
| Vanguard group | 1.06M | 3.54% | $2.33M |
| Goldman sachs group | 741.55K | 2.52% | $949.18K |
| Blackrock | 533.36K | 1.82% | $682.71K |
| Marshall wace, llp | 573.86K | 1.62% | $1.93M |
| Blackrock funding, inc. /de | 422.76K | 1.19% | $1.42M |
| Two sigma advisers, lp | 248.70K | 0.85% | $318.34K |
| Geode capital management | 208.39K | 0.70% | $458.60K |
| Southport management | 245.00K | 0.69% | $825.65K |
| Northern trust | 158.92K | 0.54% | $203.41K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Southport management | 245.00K | 4.03% | $825.65K |
| Flower city capital | 32.03K | 0.06% | $107.94K |
| Tidemark | 44.40K | 0.05% | $149.63K |
| Xtx topco | 26.83K | 0.00% | $90.41K |
| Bridgeway capital management | 51.35K | 0.00% | $112.97K |
| Marshall wace, llp | 573.86K | 0.00% | $1.93M |
| Kingsview wealth management | 14.00K | 0.00% | $47.18K |
| Two sigma advisers, lp | 248.70K | 0.00% | $318.34K |
| Citadel advisors | 1.88M | 0.00% | $2.41M |
| First manhattan co. llc. | 32.33K | 0.00% | $108.94K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Goldman sachs group | 741.55K | 0.00% | 287.31K |
| Two sigma advisers, lp | 248.70K | 0.00% | 248.70K |
| Blackrock funding, inc. /de | 422.76K | - | 106.23K |
| Susquehanna group, llp | 88.76K | - | 88.76K |
| Flower city capital | 32.03K | 0.06% | 32.03K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Cormorant asset management, lp | - | - | -3.30M |
| Blackrock | 533.36K | - | -843.76K |
| Price t rowe associates inc /md/ | - | - | -659.01K |
| Renaissance | - | - | -349.10K |
| Highvista strategies | - | - | -254.51K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Two sigma advisers, lp | 248.70K | 0.00% | 248.70K | $318.34K |
| Flower city capital | 32.03K | 0.06% | 32.03K | $107.94K |
| Kingsview wealth management | 14.00K | 0.00% | 14.00K | $47.18K |
| Russell investments group | 6.59K | - | 6.59K | $8.44K |
| Macquarie group | 1.14K | - | 1.14K | $1.45K |
Sold Out
| Holder | Change |
|---|---|
| Nelson, van denburg & campbell wealth management group | -4.00 |
| Nisa investment advisors | -10.00 |
| Point72 (difc) | -16.00 |
| Farther finance advisors | -80.00 |
| Us bancorp \de\ | -228.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2025 | 39 | 14.71% | 3,829,641 | -14.87% | 10 | 6.72% | 19 | 46.15% | 6 | -33.33% |
| Mar 31, 2025 | 3 | -92.86% | 288,934 | -93.28% | - | 0.39% | 2 | -89.47% | 1 | -90.00% |
| Dec 31, 2024 | 23 | -39.47% | 2,290,179 | -47.42% | 7 | 3.60% | 9 | -40.00% | 5 | -70.59% |
| Sep 30, 2024 | 38 | -30.91% | 4,355,311 | -54.58% | 14 | 1.37% | 15 | -58.33% | 17 | - |
| Jun 30, 2024 | 55 | 10.00% | 9,588,469 | -19.23% | 32 | 1.98% | 36 | 80.00% | 17 | -29.17% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 707.17K | 1.97% | -15.62K |
| T. Rowe Price Health Sciences | 431.83K | 1.20% | -6.52K |
| Vanguard Institutional Extnd Mkt Idx Tr | 269.10K | 0.75% | -20.10K |
| Fidelity Select Biotechnology | 161.00K | 0.45% | 161.00K |
| Fidelity Extended Market Index | 120.67K | 0.34% | -315.00 |
| Extended Equity Market Fund K | 77.01K | 0.21% | 77.01K |
| TD Health Sciences - I | 75.44K | 0.21% | - |
| NT R2000 Index Fund - NL | 60.79K | 0.20% | -260.00 |
| NT R2000 Growth Index Fund - NL | 52.97K | 0.18% | - |
| iShares Micro-Cap ETF | 62.08K | 0.17% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jul 02, 2025 | HAUSMAN DIANA | - | Buy | $8.99K |
| Jul 02, 2025 | HAUSMAN DIANA | - | Buy | $10.87K |
| Jul 02, 2025 | Neufeld Leah R | CHIEF PEOPLE OFFICER | Buy | $2.50K |
| Jul 01, 2025 | Zeskind Benjamin J. | PRESIDENT AND CEO | Buy | $10.09K |
| Jul 02, 2025 | Zeskind Benjamin J. | PRESIDENT AND CEO | Buy | $24.79K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q3 | 2 | - |
| 2025 Q2 | 7 | - |
| 2025 Q1 | - | - |
| 2024 Q3 | - | - |
| 2024 Q2 | - | 8 |
IMRX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools